According to Bloomberg, the Zylox-Tonbridge IPO ($330m) is 1000x oversubscribed and valuing the company at 52x forward 2-yr sales... Chinese medical device company targeting stroke intervention (clot retrieval, balloon catheters etc.). The Chinese market for these products is currently 90% foreign (non-China) owned yet the product offerings are pretty similar.
Obviously a different kettle of fish to what we are looking at here but the theme of ageing populations (and associated medical issues) is being highlighted by the excitement over this IPO.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.32 |
Change
0.000(0.00%) |
Mkt cap ! $198.3M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 260 | $2.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.30 | 723 | 1 |
View Market Depth
| Last trade - 09.40am 15/09/2025 (20 minute delay) ? |
| EMV (ASX) Chart |
Day chart unavailable